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Abstract:  This paper demonstrates the essential and efficient methods to design, and fabricate optimal vascular network 
for tissue engineering structures based on their physiological conditions. Comprehensive physiological requirements in both 
micro and macro scales were considered in developing the optimisation design for complex vascular vessels. The optimised 
design was then manufactured by stereolithography process using materials that are biocompatible, elastic and surface 
bio-coatable. The materials are self-developed photocurable resin consist of BPA-ethoxylated-diacrylate, lauryl acrylate 
and isobornylacrylate with Irgacure® 184, the photoinitiator. The optimised vascular vessel offers many advantages: 1) it 
provides the maximum nutrient supply; 2) it minimises the recirculation areas and 3) it allows the wall shear stress on the 
vessel in a healthy range. The stereolithography manufactured vascular vessels were then embedded in the hydrogel seeded 
with cells. The results of in vitro studies show that the optimised vascular network has the lowest cell death rate compared 
with a pure hydrogel scaffold and a hydrogel scaffold embedded within a single tube in day seven. Consequently, these 
design and manufacture routes were shown to be viable for exploring and developing a high range complex and specialised 
artificial vascular networks. 
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1. Introduction
Successfully producing full skin models with an overall 
thickness of several millimetres is a significant goal in 
skin tissue engineering. Full skin models can be used 
as implants or grafts to replace damaged skin or used to 
reduce and replace animal testing in the pharmaceutical 
industry[1,2]. The most significant challenge in producing 
full thickness skin models is that the artificial skin 
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needs to develop adequate vascularisation for long-term 
survival[3]. Without a functional vascular network, the 
diffusion of oxygen is limited to a distance of 100–200 
microns[4]. This can be addressed by pre-embedding 
an artificial vascular network into the skin scaffolds. 
The embedded network has two primary functions: 
1) to supply nutrients and other soluble factors and 
remove waste products from the surrounding cells and 
2) to develop small sprouting capillaries that can be 
connected with existing blood vessels, also known as 
angiogenesis[5-8]. Nutrition supply in the human body 
is realized by a very complex blood vessel network. 
It consists of vessels in dimensions between several 
millimetres down to several micrometres in diameter. 
To mimic this system, flexible structuring processes are 
needed. Traditional manufacturing technologies, such 
as spinning, dip-coating or extrusion, can produce linear 
tubes with different inner-diameters[9]. However, it is not 
possible to generate branched vessels, with decreasing 
or increasing internal diameters to mimic the natural 
changes in blood vessel networks.
With Additive Manufacturing (AM), three-dimensional 
(3D) objects can be produced from 3D computer-aided 
design (CAD) data by joining materials together using 
a layer-by layer manner. It is been employed widely 
in fabricating scaffolds and complete constructions 
for tissue engineering applications. There are many 
AM techniques served as bioprinting systems, such as 
microvalve-based, ink-jetting based, extrusion-based 
and stereolithography (SLA)-based techniques[10,11]. The 
use of these AM technologies will enable the generation 
and mimicking of complex blood vessel networks under 
controlled conditions. It offers the freedom to design a 
vascular network. Currently, some research groups have 
successfully constructed and tested branched vascular 
vessels[5,12–16]. Wu et al.[14] used fugitive inks to print solid 
template within the substrate and then removed the ink to 
create microchannels. Hinton et al.[17] invented a freeform 
reversible embedding of suspended hydrogels method 
(called FRESH in their paper) to print hydrated materials 
which enable printing of complex vascular architectures. 
However, in their work, vascular networks were printed 
with little understanding of the physiological demands. 
There is currently a lack of detailed and validated 
guidance for the design of artificial vascular networks of 
skin scaffolds.
In our previous work[18,19], a set of design rules were 
developed for designing one single artificial vascular 
branch made by 3D printing. This paper focuses on 
further development of design rules for complex artificial 
vascular networks based on multiscale physiological 
demands. At the microscale, the local bifurcation design 
needs to ensure that the shear stress on the vessel wall 
is in the healthy range. The wall shear stress (WSS) is a 
critical hemodynamic indicator that affects endothelial 
cell development[20–23].  WSS outside the normal 
range between 1Pa to 7Pa[24] is considered harmful to 
vessel development and may lead to cardiovascular 
diseases[20,25,26]. Many researchers have found that the 
branching angles have a significant effect on WSS 
in the bifurcation of a branch vessel[27–31].  Another 
physiological requirement at the micro-scale is to ensure 
minimal recirculation areas where nutrient and oxygen 
may be trapped. At the macro-scale, the main objective 
of the design is to maximise the nutrient supply and the 
waste exchange to surrounding tissues and cells. This 
can be achieved in two ways: firstly, the blood resistance 
needs to be minimized to use minimal energy supplying 
surrounding cells; secondly, the artificial network needs 
to cover the greatest area of the skin patch to achieve 
a satisfactory and uniform nutrient supply. While 
the final design will be limited to a two-dimensional 
geometry; it could be converted to enable 3D structures 
by stacking repeated copies. The optimized vascular 
network will be then constructed using SLA. SLA has 
advantages in printing micro vascular vessel networks 
due to 1) its high resolution, 2) its ability to produce 
flexible materials and 3) its easy to control ability. The 
photocurable resin used in the project has advantages 
of elasticity, biocompatibility and surface readiness for 
“bio-coatability”. Preliminarily physical validations 
were carried out in vitro to show that the optimised 
artificial vascular network can support cells in an adipose 
scaffold. Though further in vitro investigation is needed 
to provide systematic results, the work presented in this 
paper provides significant results to tissue engineering 
researchers. Together with previous studies, a complete 
design methodology for 3D printing an artificial vascular 
network has been fully developed and preliminarily 
tested.
2. Design Rules of Vascular Network
Previous design approaches to optimise a vascular 
network have been based on the minimisation of the 
sum of the energy required for pumping blood through 
the network and the energy required for the metabolic 
supply of the blood volume. To minimize the energy, 
Murray’s law is applied[32,33]:
                                                               (1)
Using Murray’s law, the radii of daughter vessels 
(Rd1 and Rd2) can be obtained based on the radius of 
their parent vessels (Rp). It has been confirmed that 
most natural vascular systems follow Murray’s law[34]. A 
volume minimisation routine was applied in the design 
method to determine the position of the branching point. 
These technologies were used recently by researchers 
to generate different vascular systems[35,36].  However, 
several issues were not considered in their research due 
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to the restrictions imposed by the traditional method used 
to manufacture the artificial vascular vessels. Firstly, 
the branches were created using straight tubes, and the 
vascular branching design was missing. The second 
issue is that nutrient diffusion through the vessel wall to 
the surrounding cells was not considered in their design. 
Unlike previous attempts, the application of 3D printing 
enables arbitrary vascular system design. In this work, 
we addressed these issues by developing comprehensive 
design rules for 3D printing artificial vascular networks 
to be embedded in tissue-engineered skin models. 
  The main parameters considered in our design 
can be described in two categories: 1) the macro-
scale parameters and 2) the micro-scale parameters. 
The macro-scale parameters include branch levels and 
branching point locations. The micro-scale parameters 
include branch angles, vessel diameters, the daughter 
vessel asymmetry ratio, the wall shear stress and the 
recirculation areas. Their definition and illustration are 
shown in Figure 1.
In Figure 1(A), branch levels and branching point 
are illustrated while Figure 1(B) demonstrates parent 
diameter Rp , daughter diameters Rd1 and Rd2, total 
branching angle α, blood velocity , viscosity , density 
 and WSS  and the recirculation areas. In the following 
sub-sections, developing the design methodology at both 
scales is the main objective. 
2.1 The macro-scale design (vascular system 
configuration design)
First of all, in this design, we focused on bifurcations 
because, in normal vasculature, around 98% of blood 
vessels bifurcate at each junction, while only 2% 
trifurcate[22,37]. We also limit our design to a 2D plane. 
3D structures can be formed by stacking some 2D 
vascular systems. The locations of the branching points 
are evenly distributed on the skin patch, which can be 
illustrated in Figure 2.
Figure 1.  The macro-scale (A) and the micro-scale (B) parameter definitions.
(A) The macro-scale parameters in the design of an artificial vascular network
(B)The micro-scale parameters in the design of one single branching area
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                                           (A)                                                             (B)                                                              (C)
Figure 2. Distributed configuration of the vascular network with different branching levels: A) 2 levels, B) 3 levels and C) 4 levels.
The position of a point  belonging to the th branching 
level and being the th on it are given by the equation 
below:
 
                                                                                     (2)
 
                
where,  A is the width of the skin patch, B is the length 
of the skin patch. This configuration is selected because 
it shows less sharp turns than Kamiya’s configuration[38], 
which minimised the volume of the vascular system. It 
also shows less agglomeration close to the branching 
points. The pressure drop at each branching point in the 
same level is set to be identical:
                                                                      (3)
Equations (4) and (5) are derived from equations (1–3) 
which enable the calculation of the length and the radius 
of each vessel in the vascular system, respectively:
               (4)
  (5)
As the main function of the artificial vascular 
network is supplying the tissue and cells with nutrients 
and removing metabolic products nutrient diffusion 
performance into the area between vessels is a 
determining design factor. Fick’s law and Michaelis-
Menten kinetics were applied to investigate the nutrient 
diffusion and cell consumption performance of the 
proposed configuration with different branching levels,
                            (6)
where D is the nutrient diffusion coefficient rate which 
is selected as , C is the concentration 
of the nutrient,  is a characteristic metabolic time which 
is depend on cells. Experimental studies[39] show that 
the metabolic rate of glucose in adipose tissue is around 
500 s and in skeletal muscle is approximately 545 s. 
The metabolic time and the diffusion coefficient can be 
combined in a characteristic length called “penetration 
depth”   defined as:
                                                                   (7)
We define a parameter P to measure the performance 
(quality) of the vascular configurations:
                                                                                  (8)
where  is the volume of the skin model occupied 
by living cells while is  the total volume of the skin 
model. The total volume is composed of the volume 
occupied by the blood vessel system (i.e. there is a 
“penalty” for the performance if a complex (i.e. large) 
vessel system is used), the volume of the substrate  
which is sufficiently supplied by nutrients, and the 
volume  which does not provide enough nutrients 
to the cells in order to survive. The threshold glucose 
concentration  which needs to be reached to supply 
cells adequately was set to  = 2.2 mM. Below this 
concentration, severe symptoms of hypoglycaemia occur. 
Finite difference method was used to solve the equation 
(6). In this work, we obtained a diagram illustrating the 
relationship between performance  and the penetration 
depth  for different levels of vascular vessels, shown 
in Figure 3.
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Figure 3. Comparison of performance P of a 5mm wide patch for 
the branching levels from 0 to 3.
Figure 4. the first version of the vascular system
In Figure 3, two conclusions can be made. Firstly, the 
value of performance P obtained from the distributed 
configuration is larger than that in the Kamiya 
configuration. Secondly, a higher-level configuration 
has a larger P using the same penetration depth. Based 
on this, it is possible to select the “least complex” 
vessel system, which is necessary to achieve the optimal 
performance. A three-level distributed configuration 
was therefore determined and it is at least complex and 
relatively high performance. The first configuration 
sketch of the vascular system is shown in Figure 4. 
2.2 Micro-scale design 
Endothelial cells are programmed to respond to 
mechanical stimulation[24–26]. Endothelial cells in vivo 
are typically exposed to, and presumably adapted to, 
a normal level of shear stress in the range of 1 Pa to 
7 Pa[24]. The endothelial stimulation theory says that 
when the WSS is higher than 7 Pa, it can damage the 
endothelial cells during vascular remodelling while a 
WSS lower than 1 Pa will form plaque due to insufficient 
mechanical stimulation on endothelial cells[24]. Therefore, 
the local geometry optimisation will take place based on 
the endothelial stimulation theory. 
According to Khamassi et al.[40], the WSS in a vascular 
bifurcation is related to two local parameters. They 
are R+, the asymmetry ratio and α, the total bifurcation 
angle. The definition of α is shown in Figure 1(B) and R+ 
is calculated using equation (9):
                                  (9)
Khamassi et al.[40] established a CFD simulation to 
analyse how  and R+ effect the minimal WSS at 
bifurcation junctions. They also generated a diagram 
to explain their correlations. This diagram is used as 
a guide for selecting the bifurcation angles shown in 
Figure 5. 
In Figure 5, the circles represent the founding WSS 
using different combinations of R+ and α. The contour 
lines in Figure 5 demonstrate the interpolated WSS 
values based on the founding values. A distinct optimum 
appears when R+ = 0.769 and α = 90.7 degrees, which 
is shown as a square in Figure 5. This diagram suggests 
that the branch angle and the asymmetry are the major 
geometry parameters of physiological bifurcations. 
The selection of bifurcation angle and the asymmetry 
should be in the range of the contour lines to lead to a 
proper function: the bifurcation angle ranges from 60° 
to 140° while the asymmetry ratio ranged from 0.6 to 1. 
Previous vascular optimisations did not consider WSS. 
The presented design rules for vascular bifurcations 
addressed this shortage. In the first version of the 
vascular system, we checked all the bifurcation angles 
and the asymmetry and found out that two bifurcation 
angles are out of the range. An algorithm was then 
developed to fix this problem automatically. 
In Figure 7(A), the farthest branch angles in the third 
branching level are out of the range discussed in Figure 5, 
which are circled. The correction algorithm is shown in 
Figure 6. The main idea is to add another turning point 
to achieve a moderate branching and turning. In Figure 6, 
the two red margins are the boundaries of the skin patch. 
The original branches in level 3 are marked as l0 and l1. 
The algorithm is described as following 6 steps:
Step 1: Choose a small value of , and then 
calculate angles  and ;
Step 2:  until    and 
;
Step 3: get the “new point”; if the new point is inside 
the patch, go to step 4; else go to Step 5;
Step 4: Update the diameters of these new vessels 
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using according to equation (5);
Step 5: Get a new l0and l1 (dashed lines in Figure 6), 
then go to step 1;
Step 6: End of the algorithm. 
By applying this algorithm, an update vascular system 
is shown in Figure 7(B).
From Figure 7(A), it is shown that sharp junctions 
are used in all bifurcation points. These sharp apices 
at junctions of bifurcated vessels need to be avoided 
because they are considered as risk factors for local 
mechanical weakness[23]. Rounding the apex at each 
junction can be one of the solutions. The authors 
developed an algorithm of computational geometry for 
the construction of vascular branches using a rounded 
apex[18,19]. CFD simulations were also carried out to test 
the design and they concluded that rounded junctions 
in the bifurcation branch result in a more uniform WSS 
distribution compared to sharp junctions. They also 
concluded that the construction generated using their 
algorithm will minimise the recirculation area and 
thus minimise the trapped nutrient and oxygen. This 
algorithm was applied to employ rounded junctions 
instead of sharp joints. the STL file of the vascular 
system will also be generated automatically[18,19] using 
this algorithm. 
2.3 The design summary and the porous vessel 
wall generation
To optimise a vascular network embedded in the skin 
patch to supply tissues and cells nutrient and oxygen, 
exchange waste and to support angiogenesis, we 
considered the design criteria in both macro-scale and 
micro-scale.  It can be described as four criteria, which 
are:
(a)To maximise the nutrient supply and waste 
exchange
(b)To minimise the resistance to blood flow
(c)To ensure the shear stress on the vessel wall is in 
the healthy range
(d)To avoid the blood recirculation. 
Using the methodology discussed in sections 2.1 and 
2.2; these four criteria can be achieved. Additionally, 
the final construction of the vascular system is easy 
to transfer to the STL file format. Actual blood vessel 
walls are of a semi-permeable material, and thus enable 
diffusion of nutrients, oxygen, waste products and CO2, 
from and to the blood flow. This function is however 
difficult to reproduce with materials compatible with AM 
techniques. Instead, our proposed solution aims to enable 
the diffusion through engineered pores in the vascular 
walls. Because of the limited spatial resolution and 
relatively slow build-up time offered by AM equipment, 
direct manufacturing of capillaries with smaller 
diameters (< 10 µm) is infeasible. The pores were also 
designed to enable angiogenesis – the natural generation 
and growth of new vessels out of the vessel pores. This 
approach allows the smaller capillaries to extend where 
Figure 5. WSS as a function of the bifurcation geometry. 
Figure 6. The correction algorithm
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Figure 7. the new version of the vascular system
they are needed the most. The pore diameters were 
engineered to maximise the diffusion rate (yielding a 
lower pore diameter bound for pore radii range), support 
angiogenesis, enable steady blood circulation inside the 
vessels and maintain their manufacturability via AM 
system (yielding an upper pore diameter boundary). The 
conical pores were selected with larger outer diameter 
pore diameter and smaller inner diameter. This type of 
pore leads to a reduction of the pore diameter without 
the formation of membranes. The design of the conical 
pore is shown in Figure 8.
3. Material and Methods 
3.1 Photocurable resin and photoinitiator 
The material selected in this work needs to have 
appropriate viscosity and polymerisation characteristics 
to allow it be printed successfully. Additionally, it also 
needs to have vessel-like properties, such as appropriate 
elasticity, biocompatibility and surface readiness for 
bio-coatability. The material chosen for this study 
consisted of three monomers plus a photoinitiator. The 
formulations are BPA-ethoxylated-diacrylate, lauryl 
acrylate and isobornylacrylate  (BLI) shown in Figure 9. 
Three types of photo-initiator were tested to select the 
most appropriate one that has the lowest cytotoxicity. 
They are Irgacure® 184, Irgacure® 2959 and Irgacure® 
369. BLI samples with three photoinitiators were 
investigated by the two methods WST-1assay (three 
replicates of each kind of a material; characteristic of 
the sample: diameter: 14 mm, height: 1–2 mm, weight: 
200 mg) and live/dead assay (characteristic of the 
sample: diameter: 14 mm, height: 2–3 mm, weight: 
300 mg). All samples were disinfected in 70 % ethanol 
for 30 min (meanwhile the samples swelled), washed 
two times for 30 min with PBS and equilibrated in cell 
culture medium. For both methods the mouse fibroblast 
cell line (3T3) was used, cultured in DMEM with 
glutamine (Biochrome AG, Berlin, Germany) containing 
10% fetal calf serum, 50 U/mL penicillin, and 50 µg/mL 
streptomycin under 5% CO2 atmosphere at 37 °C.   
For l ive/dead assay the cells  were seeded at 
25,000 cells/cm2, and after 1, 4 and 14 days, the cells 
Figure 8. the design of the conical pore on the vascular vessel wall.
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on the samples were stained by adding a twofold 
concentrated solut ion consis t ing of  30 µg/mL 
fluorescein diacetate (FDA) and twofold GelRed (VWR 
International, Darmstadt, Germany). Fluorescence 
staining was captured by Axiotech microscope with 
filter sets FS09 and FS14 (Carl Zeiss Microscopy, 
Jena, Germany). Living cells showed a bright green 
fluorescence, whereas dead nuclei appeared in red. 
Fluorescence micrographs from BLI samples had to 
be contrasted by image processing due to the high 
background fluorescence.
In the WST-1 assay, eluates from different specimens 
were tested for cytotoxic components. The specimens 
were eluted by incubation in complete cell culture 
medium for 24 h and following periods at 37 °C. 
According to ISO norm 10993-5 a volume of 1 mL 
medium was applied per 0.2 g material. Eluate samples 
were taken after 1, 2, 3, 6, 7, 8, 9, 10, 13, 15, 17, 21 
and 24 days and the medium was completely renewed. 
The elution period day 0–1, 1–2, 2–3, 6–7, 10–13 and 
21–24 was finally tested. For this 3T3 cells have been 
pre-cultured for one day in a 96 well tissue culture 
plate inoculated with care with about 8,000 cells per 
well. Then the medium was changed against the eluate 
samples (four replicates from each eluate sample 
resulting in 12 replicates representing the same material 
sample) and cells were incubated with the eluates for 
24 hours under cell culture conditions at 37 °C in a 5% 
CO2 atmosphere. The negative control (representing no 
cytotoxic influence) received pure cell culture medium 
whereas the positive control (representing highest level 
of cytotoxicity and complete inhibition of dehydrogenase 
activities) were obtained from wells without cells 
containing only culture medium. Eluate samples and 
controls were changed after 24 hours against medium 
with WST-1® reagent but without phenol red and 
cultured for about 20 minutes to 1 hour. Formation of 
coloured formazan was measured by the optical density 
at 450 nm. The development of dye intensity was kept 
under control to measure at a time point, when the 
optical density of the negative control was between 0.2 
and 0.6.  Relative dehydrogenase activity was calculated 
after subtracting the mean of the positive controls by 
dividing the obtained values through that of the averaged 
negative controls according to . By 
this procedure measured activities were placed on a scale 
between 0 (positive control) and 1.0 (negative control) 
or above.
3.2 AM manufacturing using stereolithography 
(SLA) 
SLA was developed in 1980’s and was one of the first 
commercial AM processes[41,42]. Conventional SLA 
machines have vertical resolutions in the range of 
150 µm. Further developments known as “micro SLA” 
can create geometries with high com plexity[43] and with 
resolutions below 150 µm in all three spatial directions. 
Behind the background of biomimetic structures, layer 
heights of less than 10 µm, e.g. allow the replication of 
capillaries that are essential for the metabolism in the 
tissue. Alternative AM methods are not able to produce 
such high-resolution structures[13,44,45]. The high resolution 
of AM cell scaffolds or membranes enables targeted cell 
alignment, cell growth and cell interaction[44,46]. The SLA 
Figure 9. Three monomers in this composite
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process relies on a photo-polymerisation process and 
suitable resins consist of monomers and photo-initiators 
(PI) that are typically toxic. Consequently, for biomedical 
applications, it is paramount to guarantee that the PI 
degrades completely during the polymerisation process. 
This challenge can only be overcome by interdisciplinary 
process improvement, including material, SLA-process 
and environmental conditions since in state-of-the-art 
implementations a typical degree of polymerisation is 
between 40–70% resulting in a considerable amount 
of remaining PI[47]. A promising approach to guarantee 
complete polymerisation and to prevent the formation 
of unwanted compounds uses inert atmosphere. Only in 
the absence of oxygen, it is possible to achieve complete 
crosslinking and full disappearance of cytotoxic PI 
and monomers. The SLA process was developed in 
this work to produce the vascular network. Figure 9 
illustrates the setup of the SLA process. It consists of a 3 
illustrates CryLaS GmbH, Germany), a scanner system 
(ProSeries PS1 Scan Heads - Cambridge Technology) 
with an F-theta lens (f=100mm) for fast beam deflection 
in x-y-direction. The polymer bath was positioned on a 
platform connected to a piezo-axis to allow positioning 
in the z-direction. For process development, different 
photo resins in combination with a photo-initiator 355 
nm were investigated. Detailed SLA setting is shown in 
Figure 10.
3.3 Degradation test method of a printed tube
Degradation tests were carried out using dip coated 
tubes and SLA fabricated tubes. Quantification method 
of degradation was similar to ISO 10993-13. Dip 
coated tubes were prepared by dipping a mandrel with a 
diameter of 1.1 mm in the BLI with Irgacure® 184 resin 
and cured manually six times for a minute under an 
argon-filled beaker by turning the mandrel gently. After 
the sample was exposed to 50% ethanol for 5 minutes, 
tubes are pull up from the mandrel, dried in vacuum and 
irradiated for another 5 minutes under an inert condition 
with UV light. SLA fabricated tubes were prepared as 
discussed in the previous section. Two groups of dip 
coated samples, and two groups of SLA fabricated tubes 
were treated at 36 °C in each case in PBS buffer or 3% 
H2O2 for two months. The difference in weight of all 
samples was determined and analysed.
3.4  In vitro testing of the vascular network
3.4.1 3.4.1. Cell Culture 
Human adipose-derived stem cells (hASCs) and 
pericytes were isolated from human tissue derived 
from patients that underwent regular surgical treatment 
and signed an informed content at the BG University 
Hospital Bergmannsheil in Bochum, Germany. The 
hASCs were cultured in DMEM-HAMS-F12, and the 
pericytes were cultured in a pericytes-growth-medium 
(PGM, PromoCell). 
3.4.2 3.4.2. Cell Seeding
In the context of the study as a scaffold methacrylated 
gelatin (5%; IGB) was used[5]. Using methacrylated 
gelatin and a photoinitiator (LAP; INN) a stable 
hydrogel was created. Within this hydrogel, three diverse 
species of cells were spread: 600,000 HUVECS, 600,000 
hASCs and 60,000 pericytes. In the hydrogel three 
different shapes of tubes were created: 1) a stainless steel 
moulded tube, 2) a single tube printed using BLI with 
Irgacure® 184 and 3) a branched network printed using 
BLI with Irgacure® 184. 
3.4.3 3.4.3. The bioreactor system
The bioreactor system was developed in[27] driven by a 
pump-sleeve-system to deliver medium (620 μL/min) 
to the hydrogels. The pump was connected to a nutrient 
bottle and the hydrogel containing chamber (see Figure 
11). To run the bioreactor system a medium mixture was 
performed in the same ratio as the corresponding cells 
were distributed. The hydrogels were at least cultured 
and 37°C and 5% CO2 for seven days.
3.4.4 3.4.4. Cell staining
After seven days a live/dead assay was performed 
s ta in ing the  hASCs wi th  Calcein  (green)  and 
Propidiumiodid (red).
Figure 10. SLA process setups.
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4. Results and Discussion 
4.1 4.1. Cytotoxicity testing for photoinitiators  
Firstly, in the live/dead assay, to evaluate the cytotoxic 
effect observable in case of direct contact of the cells to 
the material, the percentage of dead cells was determined 
by manually counting live and dead cells from 
fluorescence micrographs (Figure 12). Below 5% dead 
cells (during longer culture below 10%) was considered 
to be not cytotoxic since this can be observed in control 
cultures too. Low cytotoxicity is assumed from 5% to 
20% dead cells, moderate cytotoxicity is from 20% to 
50%, and high cytotoxicity is above 50%. Already the 
viability staining revealed the high cytotoxicity of BLI 
with Irgacure® 2959, where no viable cells could be 
detected even at higher magnification. In contrast, cells 
at BLI with Irgacure® 184 and at BLI with Irgacure® 369 
developed higher cell densities from about 135–225 to 
360–625 cells/mm2 during culture time and had less than 
10% dead cells (Table 1).
The results of the WST-1 assays are presented in 
Figure 13 as boxplot diagrams for each kind of material 
and the different periods of elution. The relative 
dehydrogenase activity was determined by subtraction 
of the averaged blank value (identical with the positive 
control) from the raw data at first, and subsequent 
division of all blank corrected values by the averaged 
negative control (defining an activity value of 1.0 (100%) 
for the metabolic rate of untreated cells). Relative 
dehydrogenase activities were divided into the categories 
“no, low, moderate, and high cytotoxicity” by the 
separation limits  0.9, 0.75, 0.5, and < 0.5. The materials 
BLI with Irgacure® 2959 and BLI with Irgacure® 369 
released cytotoxic compounds during the first two days 
of elution: revealing moderate to strong cytotoxicity at 
day 1 and weak to moderate cytotoxicity at day 2. The 
material Irgacure® 184 did not cause cytotoxicity at day 
1 and a weak moderate at day 2.
BLI with Irgacure® 184 showed no to low cytotoxicity 
in both live/dead and WST-1 assay. For the sample BLI 
with Irgacure® 2959, very high cytotoxicity was found 
in the live/dead assay. Although for the sample BLI with 
Irgacure® 369 no or only low cytotoxicity was observed 
in the live/dead assay, a release of cytotoxic compounds 
was detected at the beginning of elution. Besides, 
the data from staining could only poorly be assessed 
because these samples showed a very high background 
fluorescence and possibly not all cells were counted. 
Therefore, BLI with Irgacure® 184 showed the best 
results in both assays. Although this kind of photocured 
tube material was not wholly free of cytotoxicity, 
it should be well accepted in the current medical 
application. 
4.2 The printed vascular vessels 
To define a reliable process regime, PI concentration 
(0.5 wt% and 1 wt%), scan speed (5–600mm/s), layer 
thickness (30µm, 100µm 150µm) and the distance 
between two lines were varied. Firstly, photo resin 
3D-03H-87, Marabu with 1wt% PI was used in printing 
to get the best set of parameters, which were 15 kHz, 
power: 10.1 mW, scan speed: 80 mm/s, line distance 
30µm and a layer thickness: 800µm. Non-crosslinked 
photo resin was washed away with ethanol (70%). Post-
curing with a UV-lamp was necessary. Linear tube 
structures have been investigated with scanning electron 
microscopy as shown in Figure 13 (A–C).
A branched vessel system was also printed from 
this material using the above parameters, shown in 
Figure 14 (D). It has been proven that this SLA system 
can print the vascular network designed in section 2. 
However, the first test material is stiff and not proven 
for biocompatibility. BLI with Irgacure® 184 was then 
printed for its use in stereolithography with the same 
set of parameters. We could show that by using the SLA 
technique, the designed branched blood vessel network 
could be structured. The structure of the printed vascular 
network using BLI with Irgacure® 184 with pores is 
shown in Figure 15. The printing accuracy of angles 
and pores was tested by flow test with dye solution. 
We could demonstrate that all pores are open. In first 
experiments we observed, that branching angles show 
irregularities due to pores or problems from data slicing. 
After correcting this a homogeneous flow through the 
vessel system was observed. Long-term studies with 
seeded surfaces and a blood equivalent have to be done 
in later studies, to show the effect on cells.
Figure 11. The bioreactor system used for the tube supported 
tissue culture. It is connected to a medium reservoir and a 
peristaltic pump delivering culture media through stainless steel 
moulded, a single BLI with Irgacure® 184 tubes or a branched BLI 
with Irgacure® 184 tubes. 
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Figure 12. Fluorescence micrographs showing representative results of viability staining of 3T3 cells cultured for one day (left column), 
4 days (middle column), and 14 days (right column) at samples of the reference material glass (A–C), at BLI with Irgacure® 184 (D–F), at 
BLI with Irgacure® 2959 (G–I), and at BLI with Irgacure® 369 (J–L).
A
LKJ
IHG
FED
CB
Table 1. Levels of cytotoxicity determined by live/dead staining.
Material Control (glass) BLI with Irgacure® 184 BLI with Irgacure® 2959 BLI with Irgacure® 369
Day 1 No cytotoxicity No cytotoxicity High cytotoxicity No cytotoxicity
Day 4 No cytotoxicity Low cytotoxicity; increased number 
of cells from day 1 to day 4
High cytotoxicity Low cytotoxicity; increased number 
of cells from day 1 to day 4
Day 14 No cytotoxicity Low cytotoxicity High cytotoxicity Low cytotoxicity
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4.3 Degradation test of a printed tube
The gravimetric analysis of the dip-coated tubes shows a 
slight mass loss of approximately -1% (-1.9%) after two 
months shaking in PBS buffer (H2O2 respectively) with 
a standard deviation of 0.5% (1.9%). The results of the 
tubes show no uniform degradation behaviour, which 
would have to be expressed in a mass decrease. In some 
measurements, even mass increases were observed, 
which could probably be due to inclusions of PBS 
salts. Overall, it is assumed that the inconsistent results 
in the stereolithographic samples are due to a non-
homogeneous production method and the results show 
no significant degradation effect rather than the washing 
out of not reacted monomers and inclusion effects 
since we could not observe structural changes of the 
samples by sight test. The more uniform results with less 
scattering of the dip-coated samples show, although very 
low mass loss both in the hydrolytic and oxidative cases. 
So we can assume a very slow degradable material.
4.4  In vitro testing 
hASCs were evaluated regarding their viability using a 
live/dead assay for seven days of culture. Results of cell 
viability are shown in Figure 17. Figure 17 illustrates the 
cell vitality within a 1 x 1 cm hydrogel supported via a 
stainless steel moulded central tube (Figure 17(A)), an 
SLA-formed branched PA tube containing pores (Figure 
17(B–C)) and a single central SLA-formed PA tube 
containing pores (Figure 17(D)). By comparing Figure 
17(A,B), it is demonstrated that the ability of a branched 
tube can support the whole volume more appropriately 
compared with the central steel tube. Additionally, it 
is also shown that the surrounding cells get in contact 
to parts of the material, infiltrating the pores (in Figure 
17(C)) and form more complex structures within the 
hydrogel (in Figure 17(D)). 
Figure 18 gives a preliminary comparison of dead cell 
rate with different embedded tubes. It can be seen from 
this picture that after seven days, cell death rate in the 
Figure 13. Results of the WST-1 assays. The Box-whisker-plots indicate the median in the centre of the box, 25th and 75th percentile by 
the lower and upper margin of the box, 10th and 90th percentile by the whiskers and values outside this range. 
Han X, et al.
    International Journal of Bioprinting (2018)–Volume 4, Issue 2 13
Figure 14. Structures of the linear tube in different scales (A to C) and the structure of the branched tube (D). 
Figure 15. the structures of the printed branched vessel network using BLI with Irgacure® 184 with pores.
Figure 16. Blot-Plot results from gravimetric study dip-coated tubes (DIP) and fabricated by SLA (Stereo) to observe hydrolytic 
degradation in PBS buffer (pH = 7.4) and oxidative degradation in 3% H2O2. 
A B
A B
C D
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branched vessel is the lowest (27%) compared with the 
pure hydrogel (35%) and hydrogel with a single tube 
(55%). 
The pure hydrogel used as a scaffold in this work has 
proven to be non-toxic and has a good biocompatibility. 
This can also be seen in Figure 18 that the pure hydrogel 
scaffold has less than 50% percent cell death rate 
after seven days. The curable resin made of BLI with 
Irgacure® 184 was proven to be biocompatible and 
cytocompatible among other photopolymers used in 
the previous testing in section. However, when a single 
tube was embedded in the scaffold, the cell death rate 
increased after seven days compared with the pure 
hydrogel scaffold. This may be a reason for sub-optimal 
nutrient supply. The cell death rate was decreased 
significantly by embedding an optimised branched 
vascular vessel network into the scaffold. It shows a 
sharp drop (from 55% to 27%) of the cell death rate. 
This testing indicates that using the optimised vascular 
network, cells viability may be improved by having a 
better oxygen and nutrient supply from the bioreactor. 
Further investigations are needed to determine the long-
term cell survival and the further behaviour of the cells 
in the bioreactor system.
5. Conclusion and Future Work
In this paper, an optimised vascular network was 
developed using a set of comprehensive design rules. 
These design rules considered the physiological 
requirements in both macro- and micro-scales. The 
optimised vascular network has several advantages: 
1) this design provides the maximum nutrient supply 
with minimal complexity; 2) this design minimises the 
recirculation areas and 3) this design allows the WSS 
on the vessel in a healthy range. Suitable photo-curable 
resin with photoinitiators was then selected based on the 
WST-1 assays and live/dead assays. The results show 
that BLI with Irgacure® 184 has the lowest cytotoxicity 
among three and it is the best candidate used in SLA for 
printing the design.  Preliminary in vitro studies were 
carried out by integrating the artificial vascular vessels 
into an adipose tissue scaffold. The in vitro study only 
has two tested time steps, and the results show that 
branched resin made vascular network has the lowest 
cell death rate compared with the pure hydrogel scaffold 
and the hydrogel scaffold embedded with a single 
tube. The design and manufacturing route for vascular 
vessels developed in this paper proven to be feasible 
Figure 17. Cell vitality within a 1 x 1 cm hydrogel supported via (A) a stainless steel moulded central tube; (B,C) a branched BLI with 
Irgacure® 184 tube containing pores; (D) single central SLA-formed BLI with Irgacure® 184 tube containing pores. 
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and have potentials to be further developed. Plan of 
the future work following this paper will be, 1) more 
in vitro experiments need to be carried out in order to 
validate the design; 2) in the current skin model, they 
surrounding hydrogel is biodegradable which allowing 
remodelling in vivo. Currently, the material (BLI) used 
to manufacture the vascular network is none or very 
slow degradable according to the degradation analysis. 
The biodegradable polymer will be used to manufacture 
the vascular network allowing remodelling; 3) top skin 
layers (epidermis and dermis) will be added to the skin 
model as complete skin integration.
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